Compounds > 1,2-dimethylimidazole
Page last updated: 2024-12-05

1,2-dimethylimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1,2-Dimethylimidazole is a heterocyclic organic compound with the formula C5H8N2. It is a colorless liquid with a pungent odor. 1,2-Dimethylimidazole is an important building block for the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. The compound is also a precursor to the synthesis of several important organic compounds, such as N-methyl-imidazole, which is used as a catalyst in organic synthesis. It is studied due to its potential applications in the pharmaceutical and agricultural industries. It is also studied for its potential to serve as a building block for the development of new materials with unique properties.'

Cross-References

ID SourceID
PubMed CID15617
CHEBI ID190967
MeSH IDM0101798

Synonyms (43)

Synonym
ec 217-101-2
q41bc3grjb ,
unii-q41bc3grjb
nsc 111174
einecs 217-101-2
imidazole, 1,2-dimethyl-
1h-imidazole, 1,2-dimethyl-
1,2-dimethyl imidazole
1h-imidazole,2-dimethyl-
nsc111174
imidazole,2-dimethyl-
1,2-dimethylimidazole
1739-84-0
nsc-111174
1,2-dimethylimidazole, 98%
inchi=1/c5h8n2/c1-5-6-3-4-7(5)2/h3-4h,1-2h3
giwqspitlqvmsg-uhfffaoysa-
D1562
CHEBI:190967
AKOS000121115
A811589
BBL011425
1,2-dimethyl-1h-imidazole
STL146532
FT-0606427
AM20090037
1h-imidazole, dimethyl-
DTXSID2061939
1,2 dimethylimidazole
n,2-dimethylimidazole
1,2-dimethyl-1h-imidazole #
W-107856
mfcd00005294
F0001-0633
AC-8725
CS-W016663
D78061
Q27286970
LS-09569
1,2-dimethylimidazole, >98%
EN300-26570
PD040814
1,2-dimethylimidazol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
imidazolesA five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.12 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index38.91 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
1-methylimidazole
1-methyl-1H-imidazole : A 1H-imidazole having a methyl substituent at the N-1 position.		1.9610imidazoles
celecoxib
[no description available]		2.1310organofluorine compound;
pyrazoles;
sulfonamide;
toluenes		cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
diclofenac
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.. diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.		2.1310amino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
aspartic acid
Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.. aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent. L-aspartic acid : The L-enantiomer of aspartic acid.		1.9810aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
acetonitrile
acetonitrile: RN given refers to unlabeled cpd. acetonitrile : A nitrile that is hydrogen cyanide in which the hydrogen has been replaced by a methyl group.		2.0510aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
2-methylimidazole
[no description available]		1.9610
triazoles
Triazoles: Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3.. triazoles : An azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.		2.05101,2,3-triazole
betadex
beta-Cyclodextrins: Cyclic GLUCANS consisting of seven (7) glucopyranose units linked by 1,4-glycosidic bonds.		2.0510cyclodextrin
heme
Heme: The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.. ferroheme : Any iron(II)--porphyrin coordination complex.. ferroheme b : Heme b in which the iron has oxidation state +2.. heme : A heme is any tetrapyrrolic chelate of iron.		1.9610
ConditionIndicatedRelationship StrengthStudiesTrials
Adenocarcinoma, Basal Cell
[description not available]		02.1310
Innate Inflammatory Response
[description not available]		02.1310
Experimental Neoplasms
[description not available]		02.1310
Angiogenesis, Pathologic
[description not available]		02.1310
Colorectal Cancer
[description not available]		02.1310
Adenocarcinoma
A malignant epithelial tumor with a glandular organization.		02.1310
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.		02.1310
Colorectal Neoplasms
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.		02.1310